Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 4:38 pm Purchase | 13G | ARBUTUS BIOPHARMA CORP ABUS | Whitefort Capital Management LP | 13,197,062 7.9% | 3,183,163 (+31.79%) | View |
| 2024-02-14 10:48 am Sale | 13G | ARBUTUS BIOPHARMA CORP ABUS | Two Seas Capital LP | 9,041,927 5.4% | -461,176 (-4.85%) | View |
| 2024-02-12 09:41 am Purchase | 13G | ARBUTUS BIOPHARMA CORP ABUS | BlackRock Inc. BLK | 10,390,300 6.2% | 1,689,908 (+19.42%) | View |
| 2023-11-21 08:00 am Purchase | 13G | ARBUTUS BIOPHARMA CORP ABUS | Two Seas Capital LP | 9,503,103 5.7% | 9,503,103 (New Position) | View |
| 2023-09-11 5:07 pm Purchase | 13G | ARBUTUS BIOPHARMA CORP ABUS | Whitefort Capital Management LP | 10,013,899 6% | 10,013,899 (New Position) | View |
| 2023-02-03 12:10 pm Purchase | 13G | ARBUTUS BIOPHARMA CORP ABUS | BlackRock Inc. BLK | 8,700,392 5.6% | 8,700,392 (New Position) | View |
| 2022-02-14 09:36 am Sale | 13G | ARBUTUS BIOPHARMA CORP ABUS | RTW INVESTMENTS LP | 2,504,493 1.7% | -3,473,862 (-58.11%) | View |
| 2021-10-20 5:13 pm Purchase | 13D | ARBUTUS BIOPHARMA CORP ABUS | Roivant Sciences Ltd. ROIV | 38,847,462 29.1% | 22,833,922 (+142.59%) | View |
| 2021-02-16 10:46 am Sale | 13G | ARBUTUS BIOPHARMA CORP ABUS | Foresite Capital Fund IV L.P. | 0 0% | -3,705,128 (Position Closed) | View |
| 2021-02-12 09:23 am Purchase | 13G | ARBUTUS BIOPHARMA CORP ABUS | RTW INVESTMENTS LP | 5,978,355 7.05% | 311,601 (+5.50%) | View |
| 2021-02-10 12:13 pm Sale | 13G | ARBUTUS BIOPHARMA CORP ABUS | MORGAN STANLEY MS | 1,438,264 1.7% | -2,059,314 (-58.88%) | View |
| 2020-07-16 4:22 pm Purchase | 13G | ARBUTUS BIOPHARMA CORP ABUS | MORGAN STANLEY MS | 3,497,578 5.1% | 3,497,578 (New Position) | View |
| 2020-02-14 1:50 pm Sale | 13G | ARBUTUS BIOPHARMA CORP ABUS | EcoR1 Capital LLC | 0 0% | -3,281,502 (Position Closed) | View |
| 2020-02-14 1:44 pm Purchase | 13G | ARBUTUS BIOPHARMA CORP ABUS | RTW INVESTMENTS LP | 5,666,754 9.12% | 1,331,008 (+30.70%) | View |
| 2020-02-13 9:10 pm Purchase | 13G | ARBUTUS BIOPHARMA CORP ABUS | Foresite Capital Fund IV L.P. | 3,705,128 6.5% | 500,000 (+15.60%) | View |
| 2019-12-09 2:15 pm Purchase | 13G | ARBUTUS BIOPHARMA CORP ABUS | Foresite Capital Fund IV L.P. | 3,205,128 5.6% | 3,205,128 (New Position) | View |
| 2019-11-05 2:42 pm Sale | 13G | ARBUTUS BIOPHARMA CORP ABUS | PRIMECAP MANAGEMENT CO | 600,000 1.06% | -3,440,900 (-85.15%) | View |
| 2019-07-16 5:43 pm Sale | 13D | ARBUTUS BIOPHARMA CORP ABUS | Lo Andrew | 0 0% | -16,013,540 (Position Closed) | View |
| 2019-07-16 5:31 pm Sale | 13D | ARBUTUS BIOPHARMA CORP ABUS | Machado Patrick | 0 0% | -16,013,540 (Position Closed) | View |
| 2019-07-16 5:30 pm Unchanged | 13D | ARBUTUS BIOPHARMA CORP ABUS | Roivant Sciences Ltd. ROIV | 16,013,540 28.2% | 0 (Unchanged) | View |